- Home
- STI vs PRTG Comparison
STI vs PRTG Comparison
Compare STI & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STI
- PRTG
- Stock Information
- Founded
- STI 2014
- PRTG 1973
- Country
- STI United States
- PRTG British Virgin Islands
- Employees
- STI N/A
- PRTG N/A
- Industry
- STI
- PRTG Oil & Gas Production
- Sector
- STI
- PRTG Energy
- Exchange
- STI NYSE
- PRTG Nasdaq
- Market Cap
- STI 15.4M
- PRTG 17.7M
- IPO Year
- STI N/A
- PRTG N/A
- Fundamental
- Price
- STI $3.34
- PRTG $7.73
- Analyst Decision
- STI
- PRTG
- Analyst Count
- STI 0
- PRTG 0
- Target Price
- STI N/A
- PRTG N/A
- AVG Volume (30 Days)
- STI 559.3K
- PRTG 51.0K
- Earning Date
- STI 05-15-2025
- PRTG 06-10-2025
- Dividend Yield
- STI N/A
- PRTG N/A
- EPS Growth
- STI N/A
- PRTG N/A
- EPS
- STI 6.72
- PRTG N/A
- Revenue
- STI N/A
- PRTG N/A
- Revenue This Year
- STI N/A
- PRTG N/A
- Revenue Next Year
- STI N/A
- PRTG N/A
- P/E Ratio
- STI $0.49
- PRTG N/A
- Revenue Growth
- STI N/A
- PRTG N/A
- 52 Week Low
- STI $2.94
- PRTG $2.10
- 52 Week High
- STI $110.50
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- STI 41.72
- PRTG 46.07
- Support Level
- STI $3.18
- PRTG $7.41
- Resistance Level
- STI $3.72
- PRTG $8.35
- Average True Range (ATR)
- STI 0.38
- PRTG 0.65
- MACD
- STI 0.07
- PRTG -0.10
- Stochastic Oscillator
- STI 42.11
- PRTG 22.65
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.